Skip to main content
    R

    Rocket Pharmaceuticals Inc (RCKT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.38
    -0.05 (-2.05%)

    Market Cap: $267.30M

    Last updated: Nov 06, 2026 at 4:26 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    62%(24/39)
    Avg Surprise
    -6.12%

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.48
    Range$0.39 - $0.67
    4 analysts
    Revenue Consensus
    $-15620020
    Range$-16727270 - $-11727270
    12 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.48$0.39 - $0.67--4--
    Sep 26
    Reported Nov 5
    		$-0.45$-0.39$-0.43 - $-0.35-15.38%Miss5
    2
    1
    30d
    		+0.0%
    Jun 26
    Reported Aug 10
    		$-0.15$0.28$-0.54 - $1.15-153.57%Miss8
    2
    1
    30d
    		+74.6%
    Mar 26
    Reported May 7
    		$-0.42$-0.45$-0.52 - $-0.39+6.67%Beat5
    1
    0
    30d
    		+25.0%
    Dec 25
    Reported Feb 26
    		$-0.38$-0.42$-0.56 - $-0.31+9.52%Beat11
    3
    4
    30d
    		+38.7%
    Sep 25
    Reported Nov 6
    		$-0.45$-0.52$-0.60 - $-0.38+13.46%Beat14
    1
    1
    30d
    		+36.6%
    Jun 25
    Reported Aug 7
    		$-0.59$-0.57$-0.60 - $-0.15-3.51%Miss16
    1
    0
    30d
    		+20.3%
    Mar 25
    Reported May 8
    		$-0.56$-0.58$-0.82 - $-0.23+3.45%Beat13
    2
    0
    30d
    		+15.2%
    Dec 24
    Reported Feb 27
    		$-0.62$-0.72$-0.80 - $-0.62+13.64%Beat13
    2
    0
    30d
    		+3.1%
    Sep 24
    Reported Nov 7
    		$-0.71$-0.75$-0.84 - $-0.65+5.33%Beat15
    No revisions (30d)
    		+5.3%
    Jun 24
    Reported Aug 5
    		$-0.74$-0.72$-0.82 - $-0.57-2.78%Miss14
    1
    0
    30d
    		+9.8%
    Mar 24
    Reported May 6
    		$-0.66$-0.68$-0.83 - $-0.50+2.94%Beat12
    No revisions (30d)
    		+9.6%
    Dec 23
    Reported Feb 26
    		$-0.64$-0.77$-0.89 - $-0.67+16.88%Beat12
    1
    0
    30d
    		+28.1%

    Key Metrics

    Valuation
    P/E Ratio-1.70EV/EBITDAN/A
    Price/FCF-1.58xFCF Yield-63.35%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-4.77%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-6.74x
    Current Ratio9.24xQuick Ratio9.24x
    Trading Statistics
    Beta0.49Avg Volume2.05M
    52-Week High$5.4552-Week Low$2.17

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.47
    SMA 20$2.38
    SMA 50$2.85
    SMA 200$3.42
    EMA 10$2.45
    EMA 20$2.48
    EMA 50$2.73
    EMA 200$3.29

    MACD

    Line: -0.08Signal: -0.12Hist: 0.04

    ADX

    ADX: 17.6+DI: 19.4-DI: 20.2

    Aroon & PSAR

    Aroon Up16.0
    Aroon Down44.0
    PSAR$2.66

    Bollinger Bands

    Upper Band$2.64
    Lower Band$2.12
    %B Position2172%(Upper)
    Band Width0.51

    RSI (14-Day)

    Neutral
    43.8

    Momentum Oscillators

    Stoch %K61.5
    Stoch %D67.9
    Williams %R-57.0
    ROC (10d)4.1%
    Momentum0.10
    CCI (20d)23.2
    MFI (14d)57.0

    Volatility Measures

    ATR (14d)$0.19(7.9%)
    StdDev (20d)0.13
    Hist Vol76.5%(High)

    Volume Flow

    VWAP$2.42
    OBV-39.0M
    AD Line-132.9M
    CMF (20d)-0.022

    Volume Metrics

    Avg Vol (20d)1.9M
    Vol Ratio0.7x
    VWMA (20d)$2.37

    Pivot Points

    R3$2.89
    R2$2.75
    R1$2.59
    Pivot Point$2.44
    S1$2.29
    S2$2.15
    S3$1.99

    Advanced Oscillators

    TSI-11.66
    Ultimate Osc47.2
    KST-109.19

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$9.19M$0$0$0$10.31M$0
    Cost of Revenue$0$0N/A$0$0$0N/A$0$0$0$5.16M$0
    Gross Profit$0$0N/A$0$0$0$4.59M$0$0$0$5.16M$0
    Operating Expenses$46.92M$48.51M$43.96M$52.25M$71.15M$64.39M$62.69M$69.42M$73.71M$67.38M$63.28M$65.43M
    R&D$29.50M$31.45M$29.35M$34.07M$42.66M$35.94M$37.36M$42.31M$46.34M$45.23M$41.74M$46.84M
    SG&A$17.43M$17.06M$14.68M$18.35M$25.02M$28.45M$25.34M$27.11M$27.37M$22.15M$21.54M$18.59M
    Operating Income$-46,922,000$-48,511,000$-43,963,000$-52,247,000$-71,149,000$-64,388,000$-62,694,000$-69,424,000$-73,712,000$-67,375,000$-63,279,000$-65,429,000
    Interest Income$347,000$161,000$690,000$709,000$483,000$1.34M$1.62M$1.33M$2.29M$3.03M$814,000$1.72M
    Interest Expense$473,000$473,000$473,000$473,000$473,000$472,000$473,000$471,000$471,000$471,000$470,000$469,000
    Income Before Tax$131.84M$-48,823,000$-43,746,000$-52,011,000$-68,919,000$-63,524,000$-61,550,000$-68,568,000$-71,889,000$-64,817,000$-62,935,000$-64,178,000
    Income Tax Expense$8.62M$0$0$0$0$0$0$0$0$0$0$0
    Net Income$123.21M$-47,594,000$-42,538,000$-50,332,000$-68,919,000$-61,334,000$-60,327,000$-66,719,000$-69,646,000$-62,054,000$-59,660,000$-61,899,000
    EBITDA$134.06M$-46,365,000$-42,834,000$-50,606,000$-68,562,000$-63,474,000$-61,556,000$-68,884,000$-73,583,000$-67,875,000$-71,512,000$-58,839,000
    EBIT$131.96M$-48,511,000$-43,963,000$-52,247,000$-68,929,000$-64,388,000$-62,694,000$-69,424,000$-73,712,000$-67,375,000$-63,279,000$-65,429,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RCKT

    News

    Rocket Pharmaceuticals Inc (9IP1.DU) Seasonal returns chart

    This article from Yahoo Finance presents a seasonality chart for Rocket Pharmaceuticals Inc (9IP1.DU), displaying the average monthly price return for the period between 2021 and 2026. The stock closed at 2.1400 EUR...

    Yahoo Finance UK•11/1/26•Somewhat-Bearish

    Vanguard reports a passive stake in Rocket Pharmaceuticals (RCKT) spanning funds and clients.

    Vanguard Portfolio Management has reported a beneficial ownership of 1,463,677 shares, representing 1.33% of Rocket Pharmaceuticals, Inc. (RCKT) as of September 30...

    Stock Titan•10/30/26•Neutral

    Rocket Pharmaceuticals, Inc. (RCKT) Seasonal returns chart

    This article from Yahoo Finance presents the seasonal returns chart for Rocket Pharmaceuticals, Inc. (RCKT). It displays the average monthly price return for the company's stock from 2016 to 2026...

    Yahoo Finance UK•10/29/26•Somewhat-Bearish

    3 Promising Penny Stocks With Market Caps Under $800M

    This article identifies three promising "penny stocks" with market caps under $800M: Rocket Pharmaceuticals (RCKT), UP Fintech Holding (TIGR)...

    Simply Wall St•10/28/26•Bullish

    Rocket Pharmaceuticals, Inc. Estimates – NASDAQ:RCKT

    This page on TradingView provides financial data and analyst estimates for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). Users can explore reported financial data, compare actual results with average, high...

    TradingView•10/24/26•Neutral

    RCKT Valuation and Fair Value

    P/E
    -1.7x
    P/FCF
    -1.6x
    P/B
    0.7x
    See GNG's fair value

    RCKT Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -4.8%
    FCF yield
    -63.4%

    RCKT Competitors

    CompanyTicker
    InfuSystems Holdings IncINFU
    Q32 Bio IncQTTB
    Century Therapeutics IncIPSC
    ARS Pharmaceuticals, IncSPRY
    Nautilus Biotechnology IncNAUT
    Anika Therapeutics IncANIK
    Precision BioSciences IncDTIL
    QuantumSi IncQSI

    Sector: Healthcare

    RCKT Analyst Ratings

    Consensus
    Hold
    Analysts
    14
    Strong Buy
    1
    Buy
    6
    Hold
    5
    Sell
    1
    Strong Sell
    1

    RCKT Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -15.7%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.48

    RCKT Earnings Date

    RCKT reports Feb 24, 2027, after the close. The date is estimated.

    RCKT ETF Holders

    GNG tracks 8 ETFs that hold RCKT. The largest weights:

    1. Fidelity Enhanced Small Cap Core ETF (FESM), 0.04% of the fund
    2. iShares Biotechnology ETF (IBB), 0.02% of the fund
    3. iShares Russell 2000 ETF (IWM), 0.01% of the fund
    4. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.01% of the fund
    5. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    Open the ETF Stock Exposure tool for RCKT

    See insider activity

    Frequently Asked Questions About RCKT

    When does RCKT report earnings?

    Rocket Pharmaceuticals Inc (RCKT) is expected to report earnings on Feb 24, 2027.

    Does RCKT pay dividends?

    Rocket Pharmaceuticals Inc (RCKT) does not currently pay a regular dividend.

    What is RCKT's market cap?

    Rocket Pharmaceuticals Inc (RCKT) has a market capitalization of $267.30M with a current stock price of $2.38.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In